What the company does
AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic for the treatment of major depressive disorder. It is also developing VLS-01, an oral …
What the weekly tape is saying
B72 closed the latest completed week at 3.44 EUR. The 4-week return is -6.5% and the 12-week return is 9.6%. Trend Signal is active, Market Dynamics is 0.58. Setup signature: Risk-first tape with a 30/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 3.46 EUR
- Vs Trend Line
- -0.6%
- Fair Value
- 2.14 EUR
- Vs Fair Value
- 60.6%
- 52W High
- 6.00 EUR
- 52W Low
- 1.73 EUR
- Drawdown
- -42.7%
- Range Position
- 40.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 3 weeks
- 52W Active Weeks
- 32
- 52W Active Breadth
- 61.5%
- Sector Scope
- DE Healthcare
- Sector Rank
- 79 of 80
- Sector Percentile
- 1.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
DE Healthcare
- Tracked Peers
- 80
- 4W Rank
- 65 of 80
- Avg 1W
- -1.6%
- Avg 4W
- 1.1%
- Trend Breadth
- 32.5%
- Positive MD
- 43.8%
DE Biotechnology
- Tracked Peers
- 12
- 4W Rank
- 7 of 12
- Avg 1W
- -3.8%
- Avg 4W
- -6.8%
- Trend Breadth
- 25.0%
- Positive RS
- 16.7%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.58
- 4W MD Change
- -24.1%
- Relative Strength
- -4.48
- 4W RS Change
- -149.7%
- Expectation
- Undecided
- Probability
- 49.26%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.5K
- 13W Average
- 13.3K
- 52W Average
- 29.7K
- Vs 13W
- 0.2x
- Vs 52W
- 0.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.9%
- 52W Volatility
- 8.9%
- Upside Weeks
- 26
- Downside Weeks
- 18
- Downside Breadth
- 34.6%
- Avg Gain / Loss
- 8.0% / -6.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- GER
- Country
- DE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 1.4B
Opportunity signals
- Trend Signal is active with a 3-week active streak.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Price is below the Trend Line, which keeps downside pressure in focus.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
- Latest weekly return ranks in the weaker part of its sector group.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 3.44 EUR | -9.5% | 3.46 EUR | 2.14 EUR | 0.58 | -4.48 | 2.5K | On |
| 5 Jun 2026 | 3.80 EUR | 0.0% | 3.46 EUR | 2.13 EUR | 0.71 | 5.84 | 3.5K | On |
| 29 May 2026 | 3.80 EUR | -0.5% | 3.46 EUR | 2.12 EUR | 0.71 | 5.28 | 476 | On |
| 22 May 2026 | 3.82 EUR | 3.8% | 3.50 EUR | 2.10 EUR | 0.66 | 7.73 | 16.3K | Off |
| 15 May 2026 | 3.68 EUR | 7.6% | 3.54 EUR | 2.09 EUR | 0.77 | 9.02 | 11.3K | Off |
| 8 May 2026 | 3.42 EUR | -1.7% | 3.58 EUR | 2.08 EUR | 0.78 | 1.09 | 27.8K | Off |
| 1 May 2026 | 3.48 EUR | -12.6% | 3.61 EUR | 2.07 EUR | 0.57 | 4.35 | 6.9K | Off |
| 24 Apr 2026 | 3.98 EUR | 9.3% | 3.64 EUR | 2.05 EUR | 0.39 | 21.60 | 35.2K | Off |
| 17 Apr 2026 | 3.64 EUR | 13.0% | 3.66 EUR | 2.04 EUR | 0.00 | 10.29 | 10.3K | Off |
| 10 Apr 2026 | 3.22 EUR | -3.0% | 3.68 EUR | 2.03 EUR | -0.32 | 2.58 | 12.4K | Off |
| 3 Apr 2026 | 3.32 EUR | 3.1% | 3.70 EUR | 2.02 EUR | -0.42 | 9.95 | 6.9K | Off |
| 27 Mar 2026 | 3.22 EUR | 2.5% | 3.72 EUR | 2.01 EUR | -0.55 | 12.21 | 21.1K | Off |
| 20 Mar 2026 | 3.14 EUR | -3.7% | 3.75 EUR | 2.00 EUR | -0.67 | 10.41 | 17.8K | Off |
| 13 Mar 2026 | 3.26 EUR | 10.9% | 3.77 EUR | 1.99 EUR | -0.65 | 10.81 | 6.2K | Off |